Holen Sie sich die Stockscreener-App
21.98
3.26%
-0.74
Handel nachbörslich:
21.98
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$22.72
Offen:
$22.44
24-Stunden-Volumen:
627.78K
Relative Volume:
0.70
Marktkapitalisierung:
$1.26B
Einnahmen:
$2.19B
Nettoeinkommen (Verlust:
$-829.17M
KGV:
-1.5425
EPS:
-14.25
Netto-Cashflow:
$-3.95M
1W Leistung:
-4.81%
1M Leistung:
-19.75%
6M Leistung:
-20.19%
1J Leistung:
-53.89%
1-Tages-Spanne:
$21.90
$22.56
1-Wochen-Bereich:
$21.90
$24.46
52-Wochen-Spanne:
$21.90
$48.37
Enovis Corp Stock (ENOV) Company Profile
Firmenname
Enovis Corp
Sektor
Branche
Telefon
(302) 252-9160
Adresse
2711 CENTERVILLE ROAD, WILMINGTON
Vergleichen Sie ENOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
21.98 | 1.30B | 2.19B | -829.17M | -3.95M | -14.25 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Eingeleitet | BTIG Research | Buy |
| 2024-10-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-06-13 | Eingeleitet | JP Morgan | Neutral |
| 2024-02-13 | Eingeleitet | Stephens | Overweight |
| 2024-01-22 | Eingeleitet | UBS | Buy |
| 2024-01-03 | Eingeleitet | William Blair | Outperform |
| 2023-12-15 | Bestätigt | Needham | Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-26 | Eingeleitet | Needham | Buy |
| 2023-05-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-11 | Eingeleitet | Goldman | Buy |
| 2022-09-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-09-12 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-28 | Eingeleitet | Argus | Hold |
| 2022-06-27 | Fortgesetzt | Loop Capital | Buy |
| 2022-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Enovis (NYSE:ENOV) Hits New 52-Week LowTime to Sell? - MarketBeat
Investment Recap: What are Enovis Corporation’s technical support levels2025 Sector Review & Trade Opportunity Analysis - baoquankhu1.vn
Ideas Watch: Is Armstrong World Industries Inc. forming higher highs and higher lowsMarket Performance Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Enovis stock hits 52-week low at $22.93 amid challenging year - Investing.com Australia
Enovis stock hits 52-week low at $22.93 amid challenging year By Investing.com - Investing.com South Africa
Enovis Corp (ENOV) Shares Down 3.93% on Jan 23 - GuruFocus
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th - The Globe and Mail
Is Enovis’ LimaCorporate Integration And Margin Push Rewriting The Investment Case For ENOV? - Yahoo Finance
Enovis Corporation (ENOV): Orthopedic Innovation and Growth Potential Drive Analyst Confidence - Insider Monkey
Assessing Enovis (ENOV) Valuation After Recent Weak Share Price Performance - simplywall.st
Oliver Engert: First Chief Administrative Officer at Enovis - Orthopedics This Week
Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga
Enovis Corporation $ENOV Shares Sold by Stephens Inc. AR - MarketBeat
Levels Update: How does Empire State Realty Trust Inc score in quality rankingsJuly 2025 Price Swings & Reliable Trade Execution Plans - baoquankhu1.vn
Enovis (NYSE:ENOV) Hits New 1-Year LowHere's Why - MarketBeat
Enovis Corporation (ENOV): A Bull Case Theory - Finviz
Is Enovis Corporation undervalued by DCF analysisPrice Action & Precise Swing Trade Entry Alerts - bollywoodhelpline.com
Can Enovis Corporation beat the S P 5002025 Historical Comparison & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Aug Big Picture: Will DT Cloud Acquisition Corporation benefit from seasonality2025 Market Sentiment & Real-Time Volume Surge Alerts - baoquankhu1.vn
Stock Market Recap: Is Enovis Corporation part of any ETFWatch List & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Support Test: Is HUBC stock showing strong momentumPortfolio Performance Summary & Weekly Breakout Watchlists - baoquankhu1.vn
March 20th Options Now Available For Enovis (ENOV) - Nasdaq
A Look At Enovis (ENOV) Valuation After Naming Oliver Engert As Chief Administrative Officer - Sahm
Enovis stock hits 52-week low at 25.43 USD By Investing.com - Investing.com Canada
Enovis Names Davide Visentin as President of International Surgical Division - MSN
William Blair Maintains Enovis Corp(ENOV.US) With Buy Rating - 富途牛牛
Enovis stock hits 52-week low at 25.43 USD - Investing.com
Enovis (NYSE:ENOV) Releases FY 2025 Earnings Guidance - MarketBeat
BTIG Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $41 - 富途资讯
Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $40 - 富途资讯
Enovis (NYSE:ENOV) Trading Down 7.3%Time to Sell? - MarketBeat
Enovis free cash flow set to improve in FY26, says Evercore ISI - TipRanks
How a Medical Device Company Uses Financial Instruments to Support Its Strategy - Citizens Bank
ENOV Earnings Expectations: Consensus Estimate Stands at $3.18 - GuruFocus
Enovis (ENOV) Surpasses EPS Expectations in Q4, Cash Flow Set to Improve - GuruFocus
Enovis (ENOV) Projects 50bps aEBITDA Expansion by 2026 - GuruFocus
Enovis Lowers Top End of 2025 Revenue Guidance - 富途资讯
Enovis to Present at J.P. Morgan Healthcare Conference - TipRanks
Is Enovis (ENOV) Elevating Execution Risk Management With Its New Chief Administrative Officer? - simplywall.st
Will Enovis Corporation stock attract more institutional investors2025 Top Gainers & Risk Controlled Stock Alerts - Улправда
Why Enovis Corporation stock could see breakout soon2025 Support & Resistance & Consistent Profit Trading Strategies - Улправда
Will Enovis Corporation stock outperform Nasdaq index2025 Earnings Impact & Real-Time Volume Analysis - ulpravda.ru
Why Enovis Corporation stock is in analyst buy zone2025 Bull vs Bear & Long-Term Safe Investment Ideas - Улправда
Is Enovis Corporation stock positioned for secular growthStop Loss & Reliable Volume Spike Alerts - Улправда
Why Enovis Corporation stock remains on watchlistsCEO Change & Community Consensus Picks - ulpravda.ru
Tributary Capital Management LLC Acquires 551,613 Shares of Enovis Corporation $ENOV - MarketBeat
Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Enovis Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 - Quiver Quantitative
Inside a medical tech company’s investor meetings at a health conference - Stock Titan
Enovis (NYSE:ENOV) Rating Increased to Strong-Buy at BTIG Research - MarketBeat
Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Weakness - Yahoo Finance
Finanzdaten der Enovis Corp-Aktie (ENOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):